Conferences
ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
ASCO GI 2022
20 - 22 Jan 2022
Moscone West, San Francisco, United States of America
The 2022 ASCO Gastrointestinal (GI) Cancers Symposium offers new, innovative findings in GI cancer treatment, research, and care.
Tumour agnostic treatments in GI cancer
Dr Nicola Normanno and Dr Katja Schmitz
Durvalumab plus chemotherapy significantly improved OS in advanced biliary tract...
Dr Do-Youn Oh - Seoul National University College of Medicine, Seoul, South Kore...
Early treatment discontinuation and early oxaliplatin discontinuation for stage ...
Dr Claire Gallois - Hôpitaux Universitaires Paris-Ouest, Paris, France
HIMALAYA: Study of tremelimumab and durvalumab as first-line therapy in patients...
Dr Ghassan K. Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA
Comparing two chemo regimen and chemoradiotherapy regimen as neoadjuvant treatme...
Dr Ken Kato - National Cancer Center Hospital, Tokyo, Japan
Nivo + chemo vs chemo as first-line treatment for advanced GC/GEJC/EAC
Dr Kohei Shitara - National Cancer Center Hospital East, Kashiwa, Japan